Melissa Murphy, MD
Associate Professor of Medicine
Division of Infectious Diseases, VAMC
Degrees:B.A. (Biology) - Reed College, 1991
M.D. - University of Health Sciences, Chicago Medical School, 1996
Residency:Medicine - Oregon Health & Science University
Fellowship:ID - OHSU/Portland VAMC, 1999-2001
Focusing on the evolution of antiretroviral resistance mutations in salvage HIV patients exposed to the newer protease inhibitors and their effect on clinical response to antiretroviral therapy.
Director of the HIV clinic at the VA and shares the responsibility for the OHSU/VA inpatient infectious diseases consult service.
- Murphy MD, Marousek GI, and S Chou. HIV Protease Mutations Associated with Amprenavir Resistance During Salvage Therapy: Importance of I54M. Journal of Clinical Virology, 2004; 30: 62-67.
- Murphy MD, O'Hearn M, and S Chou. Fatal Lactic Acidosis and Acute Renal Failure After Addition of Tenofovir to an Antiretroviral Regimen Containing Didanosine. Clinical Infectious Diseases. 2003; 36: 1082-1085.
- Murphy MD, Rosen HR, Marousek GI, and S Chou. Analysis of Sequence Configurations of the ISDR, PKR-binding domain, and V3 Region as Predictors of Response to Induction Interferon-* and Ribavirin Therapy in Chronic Hepatitis C Infection. Digestive Diseases and Sciences. 2002; 47: 1195-1205.
- Desai SS, Harrison RA and MD Murphy. Capnocytophaga ochracea causing severe sepsis and purpura fulminans in an immunocompetent patient. Journal of Infection (2007) 54, e107-109